These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28363336)

  • 1. Active efflux in dormant bacterial cells - New insights into antibiotic persistence.
    Pu Y; Ke Y; Bai F
    Drug Resist Updat; 2017 Jan; 30():7-14. PubMed ID: 28363336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells.
    Pu Y; Zhao Z; Li Y; Zou J; Ma Q; Zhao Y; Ke Y; Zhu Y; Chen H; Baker MAB; Ge H; Sun Y; Xie XS; Bai F
    Mol Cell; 2016 Apr; 62(2):284-294. PubMed ID: 27105118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of bacterial persistence and phenotypic antibiotic resistance.
    Cui P; Xu T; Zhang WH; Zhang Y
    Yi Chuan; 2016 Oct; 38(10):859-871. PubMed ID: 27806927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-based regulation in type I toxin-antitoxin systems and its implication for bacterial persistence.
    Berghoff BA; Wagner EGH
    Curr Genet; 2017 Dec; 63(6):1011-1016. PubMed ID: 28560584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics.
    Defraine V; Fauvart M; Michiels J
    Drug Resist Updat; 2018 May; 38():12-26. PubMed ID: 29857815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Bacterial Persisters Dormant Cells Only?
    Zou J; Peng B; Qu J; Zheng J
    Front Microbiol; 2021; 12():708580. PubMed ID: 35185807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
    Hofsteenge N; van Nimwegen E; Silander OK
    BMC Microbiol; 2013 Feb; 13():25. PubMed ID: 23379956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms and clinical implications of bacterial persistence.
    Michiels JE; Van den Bergh B; Verstraeten N; Michiels J
    Drug Resist Updat; 2016 Nov; 29():76-89. PubMed ID: 27912845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General Mechanisms Leading to Persister Formation and Awakening.
    Wilmaerts D; Windels EM; Verstraeten N; Michiels J
    Trends Genet; 2019 Jun; 35(6):401-411. PubMed ID: 31036343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plausible role of bacterial toxin-antitoxin system in persister cell formation and elimination.
    Paul P; Sahu BR; Suar M
    Mol Oral Microbiol; 2019 Jun; 34(3):97-107. PubMed ID: 30891951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deacylated tRNA Accumulation Is a Trigger for Bacterial Antibiotic Persistence Independent of the Stringent Response.
    Wood WN; Mohler K; Rinehart J; Ibba M
    mBio; 2021 Jun; 12(3):e0113221. PubMed ID: 34126764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum.
    Ayrapetyan M; Williams TC; Baxter R; Oliver JD
    Infect Immun; 2015 Nov; 83(11):4194-203. PubMed ID: 26283335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxin-Antitoxin Systems and their Role in Maintaining the Pathogenic Potential of Causative Agents of Sapronoses.
    Andryukov BG; Somova LM; Timchenko NF; Bynina MP; Lyapun IN
    Infect Disord Drug Targets; 2020; 20(5):570-584. PubMed ID: 31322076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarifying the Link between Toxin-Antitoxin Modules and Bacterial Persistence.
    Ronneau S; Helaine S
    J Mol Biol; 2019 Aug; 431(18):3462-3471. PubMed ID: 30914294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosome dependence of persister cell formation and resuscitation.
    Wood TK; Song S; Yamasaki R
    J Microbiol; 2019 Mar; 57(3):213-219. PubMed ID: 30806978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation, physiology, ecology, evolution and clinical importance of bacterial persisters.
    Van den Bergh B; Fauvart M; Michiels J
    FEMS Microbiol Rev; 2017 May; 41(3):219-251. PubMed ID: 28333307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas syringae pv.
    Patel RR; Kandel PP; Traverso E; Hockett KL; Triplett LR
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria.
    Gefen O; Gabay C; Mumcuoglu M; Engel G; Balaban NQ
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6145-9. PubMed ID: 18427112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.